“…Each structure was labeled as 0, 1, or 2 (patent, partially obstructed, and completely obstructed, respectively). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…To evaluate their auscultation skills, students participated in five assessments using the same six pathologies: stenosis and regurgitation of the aortic and mitral valve, ventricular septal defect, and patent ductus arteriosus. Moreover, participants rated their satisfaction with each course and provided a self-assessment of competence. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The accuracy of results is challenged by antibody waning after convalescence and by cross-reactivity induced by previous infections with other pathogens. By employing a patented platform technology based on capturing antigen-antibody complexes with a solid-phase-bound Fcγ receptor (FcγR) and truncated nucleocapsid protein as the antigen, two SARS-CoV-2 IgG enzyme-linked immunosorbent assays (ELISAs), featuring different serum and antigen dilutions, were developed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Here, we isolated and patented a Bacillus amyloliquefaciens strain, and used it to verify the antagonistic effect of B. amyloliquefaciens on S. sclerotiorum and to explore the possible underlying mechanism. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Finally, we collected clinical patient samples and verified the expression of ANXA3 by qRT-PCR in patents with T2DM and fracture non-union. In conclusion, this is the first genomics study on the effect of T2DM on fracture healing. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Some embolic sources (high-risk sources: arterial myxoma, dilated cardiomyopathy, and intracardiac thrombus; medium-risk sources: atrial septal defect, nonbacterial thrombotic endocarditis, patent foramen ovale, and left ventricular hypokinesis) and uncommon causes (vascular diseases: reversible cerebral vasoconstriction syndrome, moyamoya disease, other vascular causes, arterial dissection, and cerebral venous thrombosis; hematologic diseases: antiphospholipid syndrome and protein S deficiency) were more prevalent in young adults than in non-young adults, and these trends decreased with age. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Patients diagnosed with advanced HCC (AJCC stage III and IV) during 1975 to 2018 were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Qualified patents were randomized into training cohort and validation cohort at a ratio of 7:3. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Treatment for rat IUA with estrogen (E2), oxytetracycline (OTC), and a traditional Chinese patent medicine GongXueNing (GXN) did not reduce the incidence of IUA, though inflammatory factor IL-6 was dramatically down-regulated (96–86%) with all three. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…[Image: see text] This study was conducted to investigate the sweetness intensity and the potential fecal microbiome modulation of galactooligosaccharides in combination with enzymatically modified mogrosides (mMV-GOS), both generated through a patented single-pot synthesis. Sweetness intensity was performed in vivo by trained sensory panelists. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: We searched the literature for published research articles, patents, and information from manufacturers of mobile devices, particularly those appropriate for low-resource settings. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Gedan Jiangya Decoction (GJD), with the patent publication number CN114246896A, was designed to treat primary hypertension. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The miRNA was quantified using the ID3EAL™ miRNA Discovery Platform from MiRXES measuring 575 circulating miRNAs using a patented qPCR technology and normalized with a standard curve from spike-in controls in each plate. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Participants were recruited through advertisements displayed at 3 workplaces, including a patent attorney’s office, a construction company, and a public relations firm. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…And several factors including chemotherapy and HIV status of PCNSL patents contributed to the CSS disparities between ADI subgroups were uncovered by MMA. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Whether atrial septal aneurysm (ASA) increases the risk of cerebrovascular ischemic events in patients with patent foramen ovale (PFO) remains controversial. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Demographic data was collected form the patents and blood samples were withdrawn from all patients and from 20 healthy controls. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Infants with PH were associated with intubation within 24 h after birth (p = 0.038), pulmonary dysplasia (p = 0.020), presence of patent ductus arteriosus (PDA; p = 0.028), a staged operation (p = 0.002), longer mechanical ventilation days (p < 0.001), oxygen requirement days (p < 0.001), parenteral nutrition (PN) days (p < 0.001), length of neonatal intensive care unit (NICU) or hospital stay (p = 0.001 and 0.002, respectively), and mortality (p = 0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients were randomly assigned to three groups. A total of 478 patents in groups A were accepted for smartphone WeChat application, 477 in groups B were accepted for conventional education plus smartphone WeChat application while group C (473 patients) was a control group. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The eye care providers first sought were patent medicine vendors 22 (26.5%), orthodox hospital 17 (20.5%), eye glass vendors 3 (3.6%), and traditional healers 3 (3.6%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Background and aim: Fuzheng Huayu Recipe (FZHY) is a Chinese patent medicine (approval No. Z20020074) included in the national medical insurance catalogue, which is mainly used for anti-hepatic fibrosis treatment of hepatitis B virus (HBV) induced liver fibrosis and liver cirrhosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso